SILO PHARMA, INC. Current Assets
SILO PHARMA, INC. (SILO) had Current Assets of $5.71 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $5.71M.
- 2026-03-31: Assets, Current $6.80M.
- 2025-12-31: Assets, Current $7.39M.
- 2025-09-30: Assets, Current $6.16M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $5.71M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.80M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $7.39M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.16M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $6.37M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $5.60M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $7.11M POS AM · filed 2026-04-14 |
| 2024-09-30 | $8.26M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $7.73M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.88M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $7.68M 10-K · filed 2025-03-28 |
| 2023-09-30 | $8.92M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.18M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $10.95M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $11.57M 10-K · filed 2024-03-25 |
| 2022-09-30 | $12.91M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $8.95M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $9.62M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $10.40M 10-K · filed 2023-03-24 |
| 2021-09-30 | $11.30M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.97M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $5.48M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.43M 10-K · filed 2022-03-28 |
| 2020-09-30 | $2.09M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.80M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $403.82K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $493.85K 10-K/A · filed 2021-05-17 |
| 2019-09-30 | $157.09K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $306.10K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $521.41K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $625.98K 10-K · filed 2020-03-20 |
| 2018-09-30 | $1.05M 10-Q · filed 2018-11-14 |
| 2017-12-31 | $1.64M 10-K · filed 2019-04-04 |
| 2013-09-30 | $1.26M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $368.68K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $10.10K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $279.00 10-Q · filed 2013-11-14 |
| 2012-09-30 | $279.00 10-Q · filed 2012-11-13 |
| 2012-06-30 | $813.00 10-Q · filed 2012-08-01 |
| 2012-03-31 | $3.71K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.75K 10-K · filed 2013-03-05 |
| 2011-09-30 | $4.58K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $25.80K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $47.48K 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |